HAL Allergy Group services

High prevalence rates illustrate the relevance of allergic research, An unmet need for novel targeted medicines that treat the underlying cause of allergic rhinitis and asthma still does exist. Until now allergen immunotherapy is the only disease modifying therapy tackling the cause of allergies. It even can reduce the risk of allergic asthma development. HAL Allergy constantly develops more effective allergen immunotherapies for root cause treatments for respiratory, venom and food allergies.

A wide range of allergens for diagnostic testing available. HAL Allergy offers a portfolio with a wide range of in vivo diagnostics of allergies in different application forms. We have all country specific common allergens as diagnostic available to be tested.

HAL Allergy applies state-of-the-art technologies to ensure the standardization and quality control of all allergen preparations. In order to do so, HAL Allergy identifies relevant allergens and to determines the allergenic activity of the extracts in order to ensure the quality of each allergen preparations. For our subcutaneous products allergoid preparations are used, allowing to administer high doses of allergens with a reduced risk of side effects. HAL Allergy is a key leader in the manufacturing, standardization and characterization of allergoid preparations.